New hope for mitochondrial disease: KL1333 aims to ease fatigue and improve daily life
Disease control
Not yet recruiting
This study tests whether the drug KL1333 is safe and effective over the long term for people with primary mitochondrial disease, a condition that affects energy production in cells. About 140 adults who completed a previous study will take KL1333 and be monitored for side effects…
Phase: PHASE2 • Sponsor: Pharming Technologies B.V. • Aim: Disease control
Last updated May 26, 2026 12:03 UTC